

Pig Brains Kept Alive Outside Body for Hours After DeathApril 18, 2019 |
Revival of disembodied organs raises slew of ethical and legal questions about the nature of death and consciousness.
Quick Read
Pig Brains Kept Alive Outside Body for Hours After DeathApril 18, 2019 |
Revival of disembodied organs raises slew of ethical and legal questions about the nature of death and consciousness.
Quick Read“2019 is the year when the training wheels come off and the world gets to see what CRISPR can really do for the world in the most positive sense,” says Fyodor Urnov, a gene-editing scientist at the Altius Institute for Biomedical Sciences in Seattle and the University of California, Berkeley
Quick Read“It’s easy to get on your high horse when you’re not in our position,” she said. “If editing an IVF embryo is the best option to mitigate the pain that a child would otherwise suffer, then give us the choice.”
Quick Read
When Medical Schools Become Less DiverseApril 17, 2019 |
Texas Tech recently announced it will no longer take race into account in admissions to its medical school—a move that might affect not only aspiring doctors, but many of their would-be patients as well
Quick Read
Post-Hong Kong: Human Genome Editing’s Brave New WorldApril 17, 2019 |
Watch now: The NAM & CSIS Commission on Strengthening America’s Health Security hosted a conversation on whether human germline genome editing should be permitted, the types of applications which might be appropriate, the standards and criteria that should be followed, and what regulatory or governance framework is needed. Panel includes our Jeffrey Kahn
Quick ReadThere’s been a lot of talk about overinvestment in interventions aimed at amyloid in the weeks since Biogen discontinued a late-stage study of aducanumab, an experimental therapy for Alzheimer’s disease
Quick Read
Facing Up To Injustice in Genome ScienceApril 16, 2019 |
Researchers from under-represented groups are making genomics more inclusive by working with communities that have been overlooked or abused
Quick ReadIn 2010, Dr. Pamela Munster mailed her saliva to 23andMe, a relatively new DNA testing company, and later opted in for a BRCA test. As an oncologist, she knew a mutation of this gene would put her at high risk for breast and ovarian cancer. She was relieved by the negative result
Quick Read